An Italian Study of the Efficacy of Atomoxetine in the Treatment of Children and Adolescents With Attention-Deficit/Hyperactivity Disorder (ADHD) and Comorbid Oppositional Defiant Disorder (ODD).

Conditions

• Attention Deficit Hyperactivity Disorder
• Oppositional Defiant Disorder

Interventions

• DRUG: atomoxetine 0.5 mg/kg/day
• DRUG: placebo
• DRUG: atomoxetine 1.2 mg/kg/day
• DRUG: atomoxetine 1.2-1.4 mg/kg/day

Sponsor

Eli Lilly and Company